Conserved Peptide with Therapeutic Potential to Overcome Nasopharyngeal Carcinoma

Authors

  • Muhaimin R
  • Widyarti S
  • Widodo N

DOI:

https://doi.org/10.31436/imjm.v13i1.490

Abstract

Nasopharyngeal carcinoma (NPC) is a squamous-cell carcinoma that arises in the upper lining epithelium of the nasopharynx. In this study, conserved peptide (Ulin-1) of Epstein-Barr virus constructed by Biomodelling and Biocomputation was tested for its ability to stimulate B cells to produce specific antibodies. Spleen cells were isolated and cultured with anti-CD3 and lipopolysaccharide (LPS), and treated or not treated with Ulin-1. Cell culture was harvested six days after incubation and analyzed by flow cytometry. Here, we demonstrated the ability of Ulin-1 to stimulate B cells to produce specific antibodies. The results of this study illustrate the importance of Ulin-1 engineered by Biomodelling and Biocomputation as both active and passive immunization agents against nasopharyngeal cancer.

Downloads

Download data is not yet available.

Downloads

Published

01.06.2014

How to Cite

R, M., S, W. ., & N, W. . (2014). Conserved Peptide with Therapeutic Potential to Overcome Nasopharyngeal Carcinoma. IIUM Medical Journal Malaysia, 13(1). https://doi.org/10.31436/imjm.v13i1.490